Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "multiple anti-inflammatory targets" concept refers to the strategy of modulating several molecular pathways or proteins involved in inflammation, rather than focusing on a single target. This approach aims to provide broader efficacy against diverse inflammatory conditions while addressing limitations seen with traditional single-target therapies. Key targets include cytokines/receptors, kinases, transcription factors, pattern recognition receptors, metabolic enzymes, and protein complexes like inflammasomes. Multi-target agents can be single drugs with pleiotropic effects or combinations of drugs targeting different pathways.
Simultaneous modulation of multiple molecular pathways or proteins involved in inflammation. This can involve inhibiting multiple enzymes or receptors, modulating upstream regulators, or blocking parallel signaling pathways.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Anti-Inflammatory Targets.